The effect of the anti-angiogenic agent TNP-470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice

Journal of Neuro-Oncology

Volumn 38, Issue 1, 1998, Pages 51-57

  Bernsen, H J J A ^a,b   Rijken, P F J W ^a   Peters, H ^a   Bakker, H ^c   Van Der Kogel, A J ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Glioma; Nude mice; Quantitative vascular analysis; TNP 470

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DENSITY; GLIOMA; HUMAN; IMAGE ANALYSIS; MOUSE; NONHUMAN; NUDE MOUSE; PERFUSION; TUMOR GROWTH; VASCULARIZATION; XENOGRAFT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL DIVISION; CYCLOHEXANES; GLIOMA; HUMANS; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; SESQUITERPENES; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031909427     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005957201431     Document Type: Article

References (24)

1. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763, 1995
2. Auerbach W, Auerbach R: Angiogenesis inhibition. A review. Pharm Ther 63: 265-311, 1994
3. Fan TP, Jaggar R, Bicknell R: Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci 16: 57-66, 1995
4. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555-557, 1990
5. Yanase T, Tamura M, Fujita K, Kodama S, Tanaka K: Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 53: 2566-2567, 1993
6. Abe J, Zhou W, Takuwa N, Kurokawa K, Kumada M, Takuwa Y: A fumagillin derivative angiogenesis inhibitor, AGM 1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogen expression in vascular endothelial cells. Cancer Res 54: 3407-3412, 1994
7. Takamiya Y, Brem H, Ojeifo J, Mineta T, Martuza RL: AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. Neurosurgery 34: 869-875, 1994
8. Takechi A, Uozumi T, Kawamoto K, Ito A, Kurisu K, Sudo K: Inhibitory effect of TNP-1470, a new anti-angiogenic agent, on estrogen induced rat pituitary tumors. Anticancer Res 14: 157-162, 1994
9. Isobe N, Uozumi T, Kurisu K, Kawamoto K: Antitumor effect of TNP-470 on glial tumors transplanted in rats. Anticancer Res 16: 71-76, 1996
10. Westphal JR, van't Hullenaar RGM, van der Laak JAWM, Cornelissen IMHA, Schalkwijk LJM, van Muijen GNP, Wesseling P, de Wilde PCM, Ruiter DJ, de Waal RMW: Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. Br J Cancer, in press
11. Rijken PFJW, Bernsen HJJA, van der Kogel AJ: Application of an image analysis system for the quantitation of the tumor perfusion and vascularity in human glioma xenografts. Microvasc Res 50: 141-153, 1995
12. Wilson JT, Penar PL: The effect of AGM-1470 in an improved intracranial 9L-gliosarcoma rat model. Neurol Res 16: 121-124, 1994
13. Konno H, Tanaka T, Matsuda I, Kanai T, Maruo Y, Nishino N, Nakamura S, Baba S: Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer. Int J Cancer 61: 268-271, 1995
14. Konno H, Tanaka T, Kanai T, Maruyama K, Nakamura S, Baba S: Efficacy of an angiogenesis inhibitor, TNP-470, in xenotransplanted human colorectal cancer with high metastatic potential. Cancer 77: 1736-1740, 1996
15. Mcleskey SW, Zhang L, Trock BJ, Kharbanda S, Liu Y, Gottardis MM, Lippman ME, Kern FG: Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells. Br J Cancer 73: 1053-1062, 1996
16. Yamamoto T, Sudo K, Fujita T: Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). Anticancer Res 14: 1-4, 1994
17. Kusaka M, Sudo K, Matsutani E, Kozai Y, Marui S, Fujita T, Ingber D, Folkman J: Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM 1470). Br J Cancer 69: 212-216, 1994
18. Hori A, Ikeyama S, Sudo K: Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM 1470) in vascular endothelial cells. Biochem Biophys Res Commun 204: 1067-1073, 1994
19. Kim KJ, Li B, Winer J, Armanini M, Gillet N, Phillips HS, Ferrara N: Inhibition of VEGF-induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841-844, 1993
20. Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn LM: Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res 56: 1615-1620, 1996
21. Bernsen HJJA, Rijken PFJW, Peters H, Bakker H, van der Kogel AJ: The effect of anti-VEGF treatment on growth of human glioma xenografts in nude mice and vascular changes following anti-angiogenic therapy. Submitted for publication
22. Teicher BA, Holden SA, Ara G, Sotomayor EA, Huang ZD, Chen YN, Brem H: Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int J Cancer 57: 920-925, 1994
23. Teicher BA, Holden SA, Ara G, Dupuis NP, Liu F, Yuan J, Ikebe M, Kakeij Y: Influence of an anti-angiogenic treatment on 9L gliosarcoma: Oxygenation and response to cytotoxic therapy. Int J Cancer 61: 732-737, 1995
24. Yanai S, Okada H, Saito K, Kuge Y, Ogewa Y, Toguchi H: Optimal formulation of an angiogenesis inhibitor, TNP-470, for arterial injection determined by in vitro drug release and stability, and in vivo antitumor activity. Int J Pharmaceutics 123: 237-245, 1995